Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pandemic H1N1 influenza vaccine incidence and immunogenicity study
NL-OMON29324Recruiting
- Sponsor
- Nederlands Vaccin Instituut
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in Influenza A infection (2 arms), sponsored by Nederlands Vaccin Instituut. Started Oct 2009; status: recruiting.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on NL-OMON29324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29324.